Following Patients With Inborn Errors of Metabolism: What Do We Value and How Do We Know?
- PMID: 34266902
- PMCID: PMC9048096
- DOI: 10.1542/peds.2021-051020
Following Patients With Inborn Errors of Metabolism: What Do We Value and How Do We Know?
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: The authors have no conflicts of interest to disclose.
Comment on
-
Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria.Pediatrics. 2021 Aug;148(2):e2020037747. doi: 10.1542/peds.2020-037747. Epub 2021 Jul 15. Pediatrics. 2021. PMID: 34266901
References
-
- COMET Initiative. Available at: https://www.comet-initiative.org/. Accessed April 1, 2021
-
- Pugliese M, Tingley K, Chow A, et al. Core outcome sets for medium chain Acyl-coA dehydrogenase deficiency and phenylketonuria. Pediatrics. 2021;148(2): e2020037747. - PubMed
-
- Paul D, Brosco JP. The PKU Paradox: A Short History of a Genetic Disease. Balti-more, MD: The Johns Hopkins University Press; 2013:111–139
-
- Powell CM. Newborn screening and long-term outcomes. Pediatrics. 2020;146(5): e2020023663. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources